Search Results - S. N. Fogt

SUCCESSFUL REGISTRATION OF DOMESTIC BIOANALOGUE OF BEVACIZUMAB – NEW OPPORTUNITIES FOR EFFECTIVE TREA TMENT OF PATIENTS WITH NON-SQUAMOUS CELL NON-SMALL CELL LUNG CANCER by S. V. Orlov, S. N. Fogt, M. S. Shustova

Get full text

IS IT POSSIBLE TO USE BEVACIZUMAB BIOSIMILAR IN ALL INDICATIONS REGISTERED FOR ORIGINAL DRUG? by S. V. Orlov, N. L. Shimanovskii, S. N. Fogt

Get full text

Сurrent status of adrenocortical cancer therapy by S. N. Fogt, V. V. Kalugina, N. V. Vorokhobina, A. V. Kuznetsova, I. P. Serebryakova

Get full text

Promising developments in the fi eld of diff erential diagnosis of benign and malignant thyroid nodules by N. V. Vorokhobina, V. L. Baranov, S. N. Fogt, F. V. Kuznetsova, K. A. Balandina, R. K. Galakhova

Get full text

Glucocorticoid-induced adrenal insufficiency by N. V. Vorokhobina, S. N. Fogt, V. I. Mazurov, I. B. Beliaeva, R. K. Galakhova, K. A. Balandina, A. V. Kuznetsova

Get full text

Toxicity Associated with Immune Checkpoint Inhibitors: Analysis of Immune-Related Adverse Events with a Pembrolizumab Biosimilar (Pembroria) by M. Yu. Fedyanin, A. V. Snegovoy, V. V. Breder, Yu. N. Linkova, A. V. Zinkina-Orikhan, S. B. Setkina, S. N. Fogt, V. S. Chistiakov, N. A. Kravtsova

Get full text